Seidenberg Beth C
Kyverna Therapeutics, Inc. · Director
Seidenberg Beth C is listed in filings as Director at Kyverna Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 29, 2026, including purchase activity and sale activity. Recent filings connect the profile to Kyverna Therapeutics, Inc. (KYTX), Vera Therapeutics, Inc. (VERA), Sagimet Biosciences Inc. (SGMT), and Acelyrin, Inc. (SLRN). The current snapshot covers public activity from Sep 20, 2024 to May 29, 2026. Reported amounts are shown as $176.8K to $1000.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $710k14.8k shares | SellOct 28, 2024 | $48.01 | $39.12 | |
| $10k202 shares | SellOct 28, 2024 | $49.54 | $39.12 | |
| $585k13.8k shares | SellSep 19, 2024 | $42.31 | $39.12 | |
| $62k1.5k shares | SellSep 18, 2024 | $42.00 | $39.12 | |
| $49k1.2k shares | SellSep 18, 2024 | $42.01 | $39.12 |